Cargando…
Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplantation? A Multicenter Comparative Analysis from India
BACKGROUND: Limited data exist on the incidence and outcome of early coronavirus disease 2019 (COVID-19) in kidney transplantation recipients (KTR). METHODS: A retrospective multicenter research study was conducted across 12 centers in India. We explored the symptomatology, demographic, laboratory f...
Autores principales: | Meshram, Hari Shankar, Kute, Vivek B., Patel, Himanshu V., Hegde, Umapati, Das, Pratik, Sil, Keshab, Sahay, Manisha, Raju, Sree Bhushan, Chaudhury, Arpita Ray, Siddini, Vishwanath, Pathak, Vivek, Bahadur, M.M., Anand, Urmila, Krishna, Amresh, Abraham, Abi, Patel, Ansy H., Mishra, Vineet, Chauhan, Sanshriti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403672/ https://www.ncbi.nlm.nih.gov/pubmed/34556343 http://dx.doi.org/10.1016/j.transproceed.2021.08.034 |
Ejemplares similares
-
Effect of Coronavirus Disease 2019 on Transplantation and Nephrology in India: A Nationwide Report From India
por: Meshram, Hari Shankar, et al.
Publicado: (2022) -
Is it safe to undergo living donor kidney transplant within 2 weeks following COVID-19?
por: Kute, Vivek B., et al.
Publicado: (2023) -
A Multicenter Cohort Study From India of ABO-Incompatible Kidney Transplantation in Post–COVID-19 Patients
por: Kute, Vivek, et al.
Publicado: (2022) -
BK polyomavirus infection following COVID-19 infection in renal transplant recipients: a single-center experience
por: Meshram, Hari Shankar, et al.
Publicado: (2021) -
COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford–AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India
por: Meshram, Hari Shankar, et al.
Publicado: (2021)